ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,118.71
0.53%
US Tech 100
21,276.80
0.08%
다우존스 지수
44,565.07
0.92%
Bitcoin
104,084.09
0.43%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Hepion Pharmaceuticals Inc (HEPA) 시세

Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals Inc (HEPA)

NASDAQ
0.20
0.065
(48.15%)
종가: 24 1월 6:00AM
15분 지연
0.1848
-0.0152
( -7.60% )
시간외 거래: 8:22AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
0.1848
매수가
0.183
매도가
0.187
거래량
538,528,682
0.156 일간 변동폭 0.3168
0.121 52주 범위 3.4899
market_cap
1.286M
전일 종가
0.135
개장가
0.1919
최근 거래 시간
101
@
0.1848
(formt)
마지막 거래 시간
08:22:47
재정 규모
US$ 107,096,768
VWAP
0.198869
평균 볼륨(3m)
727,071
발행 주식
6,958,371
배당수익률
-
주가수익률
-0.03
주당순이익(EPS)
-7.03
매출
-
순이익
-48.93M

Hepion Pharmaceuticals Inc 정보

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.hepion.com
본부
Wilmington, Delaware, USA
설립됨
-
Hepion Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker HEPA. The last closing price for Hepion Pharmaceuticals was US$0.14. Over the last year, Hepion Pharmaceuticals shares have traded in a share price range of US$ 0.121 to US$ 3.4899.

Hepion Pharmaceuticals currently has 6,958,371 shares in issue. The market capitalisation of Hepion Pharmaceuticals is US$939,380.09 . Hepion Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.03.

HEPA 최신 뉴스

추가 뉴스

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

EDISON, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...

22 1월 2025
GlobeNewswire Inc.

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

13 1월 2025
Edgar (US Regulatory)

Form 8-K - Current report

11 12월 2024
Edgar (US Regulatory)

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a...

11 12월 2024
GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

05 12월 2024
Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

02 12월 2024
Edgar (US Regulatory)

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Transaction Creates Opportunity to Share in Potential Upside of Pharma Two B’s Late-Clinical Stage Candidate to Treat Parkinson’s Disease Hepion’s Board Unanimously Recommends Shareholders...

02 12월 2024
GlobeNewswire Inc.

Form 425 - Prospectuses and communications, business combinations

22 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

22 11월 2024
Edgar (US Regulatory)

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

KIRYAT ONO, ISRAEL and EDISON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination...

11 11월 2024
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.2552-580.440.52790.12194438530.14716861CS
4-0.3142-62.96593186370.4990.73450.12122945940.16025552CS
12-0.4562-71.17004680190.6410.740.1217270710.17147517CS
26-0.5752-75.68421052630.760.890.1213477550.22015512CS
52-1.8952-91.11538461542.083.48990.1212300950.49346994CS
156-19.4412-99.058391929119.62626.60.12125773410.5581445CS
260-103.6152-99.8219653179103.81500.12191805539.17995854CS

HEPA - Frequently Asked Questions (FAQ)

What is the current Hepion Pharmaceuticals share price?
The current share price of Hepion Pharmaceuticals is US$ 0.1848
How many Hepion Pharmaceuticals shares are in issue?
Hepion Pharmaceuticals has 6,958,371 shares in issue
What is the market cap of Hepion Pharmaceuticals?
The market capitalisation of Hepion Pharmaceuticals is USD 939.38k
What is the 1 year trading range for Hepion Pharmaceuticals share price?
Hepion Pharmaceuticals has traded in the range of US$ 0.121 to US$ 3.4899 during the past year
What is the PE ratio of Hepion Pharmaceuticals?
The price to earnings ratio of Hepion Pharmaceuticals is -0.03
What is the reporting currency for Hepion Pharmaceuticals?
Hepion Pharmaceuticals reports financial results in USD
What is the latest annual profit for Hepion Pharmaceuticals?
The latest annual profit of Hepion Pharmaceuticals is USD -48.93M
What is the registered address of Hepion Pharmaceuticals?
The registered address for Hepion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Hepion Pharmaceuticals website address?
The website address for Hepion Pharmaceuticals is www.hepion.com
Which industry sector does Hepion Pharmaceuticals operate in?
Hepion Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STBXStarBox Group Holdings Ltd
US$ 1.01
(98.00%)
7.72M
EVAXEvaxion Biotech AS
US$ 5.20
(42.86%)
2.95M
NVNINVNI Group Ltd
US$ 2.0005
(34.26%)
3.02M
TRUGTruGolf Holdings Inc
US$ 0.5801
(19.61%)
2.33M
DWTXDogwood Therapeutics Inc
US$ 15.4999
(16.10%)
2.07M
HYZNHyzon Motors Inc
US$ 0.5503
(-28.72%)
173.67k
VINCVincerx Inc
US$ 0.1084
(-16.03%)
2.17M
SMLRSemier Scientific Inc
US$ 53.10
(-13.16%)
111.11k
ICCTiCoreConnect Inc
US$ 2.391
(-13.05%)
219.15k
DGNXDiginex Ltd
US$ 11.16
(-12.47%)
43.06k
ACONAclarion Inc
US$ 0.0475
(9.95%)
14.01M
HPHHighest Performances Holdings Inc
US$ 0.249
(1.97%)
12.72M
STBXStarBox Group Holdings Ltd
US$ 1.0099
(97.98%)
7.75M
HEPAHepion Pharmaceuticals Inc
US$ 0.1839
(-8.05%)
7.25M
RIMEAlgorhythm Holdings Inc
US$ 0.0341
(0.00%)
6M

HEPA Discussion

게시물 보기
knrorrel knrorrel 4 시간 전
Bounce time now
👍️0
knrorrel knrorrel 4 시간 전
$HEPA nice , starting
👍️0
knrorrel knrorrel 4 시간 전
LET'S GOOOOO
👍️0
knrorrel knrorrel 4 시간 전
$HEPA 👀👀👀 now
👍️0
Cornwhale Cornwhale 5 시간 전
Hepa
👍️ 1
Timing101 Timing101 6 시간 전
$HEPA watch this into the last part of trading today. That offering is TWICE what it is running now and has lived at .50 range or above for Months. Upward pressure going on now.
👍️0
willlbone willlbone 2 일 전
Trump dump.
👍️0
tw0122 tw0122 3 월 전
HEPA give it a holler .85 + 40%
👍️0
blue finch blue finch 5 월 전
i remember you from vitra
we all
made money
👍️0
Ruffieruff Ruffieruff 5 월 전
Yup. Seem to find em all.
👍️0
blue finch blue finch 5 월 전
ugh
Another scam
WTF
👍️0
Monksdream Monksdream 6 월 전
HEPA new 52 week low
👍️0
Monksdream Monksdream 6 월 전
HEPA new 52 week low
👍️0
Monksdream Monksdream 6 월 전
HEPA new 52 week low
👍️0
Ruffieruff Ruffieruff 6 월 전
Scam. All shareholders continues to get screwed.
👍️0
Monksdream Monksdream 6 월 전
Whoops, I did it, again
👍️0
Awl416 Awl416 6 월 전
Pharma Two B Announces Plans to Go Public via Merger with Hepion Pharmaceuticals, Inc. and Concurrent $11.5 Million Private Placement
👍️0
Monksdream Monksdream 6 월 전
HEPA under $2
👍️0
Monksdream Monksdream 7 월 전
HEPA under $2
👍️0
Awl416 Awl416 9 월 전
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
👍️0
Monksdream Monksdream 12 월 전
HEPA new 52 week low
👍️0
Monksdream Monksdream 12 월 전
HEPA new 52 week low
👍️0
Ruffieruff Ruffieruff 2 년 전
POS
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 년 전
Any thoughts on whether they could see accelerated approval now? results were good and there are no good alternatives.
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 년 전
What if it is a lush partnership instead?
👍️0
shurtha2000 shurtha2000 2 년 전
Thanks
👍️0
Disquisition Disquisition 2 년 전
Absolutely correct, sir
👍️0
make it happen make it happen 2 년 전
Don't forget it's a delinquent stock has failed to meet requirements ie r/s to raise more funds rinse and repeat for at least another 3 years and if one bad thing happens expect a 90% haircut immediately imho
👍️0
Disquisition Disquisition 2 년 전
people DUMPING knowing the OFFERING is imminent…
👍️0
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 2 년 전
GOOD CALL: after R/S This could be a moon shot on good top line results
👍️0
da_stock_analyst da_stock_analyst 2 년 전
#HEPA ?? 117% move today! Looking strong and ready for tomorrow! $HEPA
👍️0
make it happen make it happen 2 년 전
R/S, huge double digit negative returns, burning capital, zero Profitability

Management Effectiveness
Return on Assets -42.63%
Return on Equity  -78.41%

Cash Flow Statement
Operating Cash Flow -33.05M
Levered Free Cash Flow -16.86M

Profitability
Profit Margin. 0.00%
Operating Margin 0.00%

Yahoo

It is losing/spending more than its market cap. Imho will fade back to singles and dilute. It can't keep operations running without selling shares to share holders.
👍️0
Disquisition Disquisition 2 년 전
Yes (for up to $350 million)

and Yes (check the latest 10Q - very little cash left on hand)
👍️0
TheFinalCD TheFinalCD 2 년 전
DO THEY HAVE A SHELF OFFERING TO DRAW FROM?

ARE THEY CURRENTLY IN NEED OF CASH FROM AN OFFERING?

Message in reply to:
Offering tonight or tomorrow. Called it
👍️0
TheFinalCD TheFinalCD 2 년 전
GOOD CALL
after R/S This could be a moon shot on good top line results
👍️ 1
Pt3 Pt3 2 년 전
Call wrong baby ....Biden say No more offering.... inflation is extremely now
👍️0
Disquisition Disquisition 2 년 전
Offering tonight or tomorrow. Called it
👍️0
Triple nickle Triple nickle 2 년 전
Might jus do it
👍️0
Triple nickle Triple nickle 2 년 전
Gotta bust thru 16.40 and hold it
👍️0
makinezmoney makinezmoney 2 년 전
$HEPA : Meeting those PRIMARY ENDPOINTS


Another MDGL kinda booster about to happen here.... now $15



GO $HEPA
👍️0
Ruffieruff Ruffieruff 2 년 전
This is not even .80c PS. Whose selling?
👍️0
shurtha2000 shurtha2000 2 년 전
$15.73 building a new base
👍️0
Disquisition Disquisition 2 년 전
DUMPED all my 7zzzz at 16
👍️0
shurtha2000 shurtha2000 2 년 전
Achieves primary and secondary endpoints its all good

https://finance.yahoo.com/news/hepion-pharmaceuticals-phase-2-altitude-110000500.html
👍️0
shurtha2000 shurtha2000 2 년 전
Will Pre-market trading be suspended ?
👍️0
tw0122 tw0122 2 년 전
830 am
Monday’s conference call update
👍️0
shurtha2000 shurtha2000 2 년 전
after R/S This could be a moon shot on good top line results
👍️ 1
Ruffieruff Ruffieruff 2 년 전
But it all. Taking knife. We are scammed.
👍️ 1
makinezmoney makinezmoney 2 년 전
$HEPA: So the RS happened........ now $9

But on a downdip........... will have to get some more if this dips sub $9


GO $HEPA
👍️0
Ruffieruff Ruffieruff 2 년 전
Your shares look like crap like the rest of us!! Pumper
👍️ 1

최근 히스토리

NASDAQ
HEPA
Hepion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유